The "fat metabolism" shelf. Read the composition before the marketing — the interesting molecule is never the carnitine.
SUPER SHRED
flagship blendWhat it is — A high-concentration lipolytic injectable built around L-carnitine 400 mg with a MIC blend (methionine/inositol/choline) 100 mg, ATP 50 mg, vitamin B12 1 mg — and albuterol 2 mg per vial.
Typical composition
L-Carnitine 400 mgMIC blend 100 mgATP 50 mgAlbuterol 2 mgB12 1 mg
Evidence — None for the combination. Each ingredient has its own, mostly weak, literature; the stack itself has never been studied in any model.
Cautions
Albuterol is a prescription beta-2 agonist — a stimulant with real cardiovascular load (tremor, tachycardia, blood pressure). Putting it in an injectable fat-loss blend sold next to vitamins is the single biggest red flag in this category. There is no legitimate framework where injecting albuterol makes sense.
Verdict — Avoid. This is not a lipolytic strategy — it is a stimulant wearing a lab coat.
Lipo-C
lipotropic blendWhat it is — The classic compounding-pharmacy lipotropic: methionine, choline, carnitine and dexpanthenol in a 10 ml vial, marketed for 'fat metabolism support'.
Typical composition
Methionine 15 mgCholine chloride 50 mgCarnitine 50 mgDexpanthenol 5 mg
Evidence — Nutrient-level at best. Injectable lipotropics have been compounded for decades without a single convincing human outcome trial behind the combination. Oral equivalents are cheaper and equally unproven.
Cautions
Quality control is entirely on the compounder — these vials circulate far outside regulated compounding. It is stimulant-free, so the main risk is paying for faith.
Verdict — Harmless, underwhelming, overpriced. If fat loss is the goal, the evidence ladder starts elsewhere.
Lipo-B
lipotropic blendWhat it is — A broader lipotropic: L-carnitine, L-arginine, methionine, inositol and choline fortified with B6, B5 and B12.
Typical composition
L-Carnitine 20 mgL-Arginine 20 mgMethionine 25 mgInositol 50 mgCholine 50 mgB6 25 mgB5 25 mgB12 1 mg
Evidence — Same story as Lipo-C — a vitamin-and-aminoacid mix with decades of marketing and no outcome data behind the injectable route.
Cautions
B6 at repeated high exposure is not free (peripheral neuropathy is documented with chronic overdose). Otherwise the risk profile is 'expensive urine via syringe'.
Verdict — The multivitamin of injectables. Fine as a B12 delivery vehicle; imaginary as a fat-loss tool.
Lipo-C [FOCUS]
enhanced blendWhat it is — Lipo-C with a stimulant and anesthetic twist: ATP, eria jarensis (a plant source of N,N-dimethylphenethylamine), carnitine, MIC, plus lidocaine 0.1% and benzyl alcohol 2%.
Typical composition
ATP 50 mgEria jarensis 50 mgL-Carnitine 200 mgMIC blend 125 mgLidocaine 0.1%Benzyl alcohol 2%
Evidence — None. Eria jarensis is a gray-market stimulant sold as a supplement; it has never been studied as an injectable and its DMAA-like alkaloids are on regulatory radar in several markets.
Cautions
A stimulant alkaloid plus a local anesthetic in one vial — the stimulant masks the injection pain and the anesthetic masks the stimulant's warning signs. That is a deliberately engineered feel-good loop, not a formulation.
Verdict — Avoid. 'FOCUS' here means 'we put a stimulant in it'.
Lipo-C [FAT BLASTER]
enhanced blendWhat it is — A NADH-fortified lipotropic: carnitine, methionine, inositol, choline, B12, B6 and NADH 50 mg.
Typical composition
L-Carnitine 300 mgMethionine 25 mgInositol 50 mgCholine 50 mgB12 1 mgB6 50 mgNADH 50 mg
Evidence — NADH injectable has thin but real literature for fatigue; the lipotropic chassis remains unproven. The whole is less than the sum of its invoice lines.
Cautions
The most benign of the enhanced line — the flag is concentration, not composition. 526 mg/ml is a lot of dissolved material per injection site.
Verdict — The least objectionable of the Lipo family. Still a vitamin shot with marketing.